This proteomics-driven approach to drug discovery improves target validation and uncovers insights into undruggable proteins, ...

Comprehensive residue-level mapping of amyloid-beta recognition reveals how sequence variants, post-translational ...

Proteomics as a concept concerns the study of the complete set of proteins expressed by an organism since the molecules carry ...

Nine-Point-Seven Percent CAGR Reflects Fundamental Industry Shift Toward Advanced LC-MS/MS and High-Resolution Platforms ...

In a bid to enhance cancer treatment and research, India is focusing on developing its own genomic evidence base, addressing ...

Osteoarthritis often goes undetected until cartilage damage is advanced, limiting treatment options. A new study shows that ...

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Cardiovascular diseases (CVDs), a leading global cause of mortality, are characterized by complex ...

Osteoarthritis often goes undetected until cartilage damage is advanced, limiting treatment options. A new study shows that molecular changes in subchondral bone occur earlier and can signal disease ...

BACKGROUND: The disruption of the blood–brain barrier (BBB) is a central pathogenic event in many central nervous system disorders. However, the mechanisms regulating BBB function remain incompletely ...

Explore AI in drug discovery and its journey from promise to proof in 2025 with significant achievements and challenges faced.

The study which compared MB310, a precision microbiome medicine, with placebo in 29 ulcerative colitis (UC) patients met its primary and ...